Jazz Pharmaceuticals plc
JAZZ
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement disorders; and in oncology, including hematologic andā¦ read more
Healthcare
Biotechnology
18 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$221.85
Price-1.74%
-$3.94
1Y
Price
Market Cap
$13.920b
Large
Price/Earnings 3y Avg5y Avg
2,016.9x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+23.3%
EBITDA Margin+17.0%
Net Profit Margin+24.8%
Free Cash Flow Margin+23.3%
EBITDA Margin+17.0%
Net Profit Margin+24.8%
Free Cash Flow MarginRevenue
$4.439b
+4.9%
1y CAGR+5.3%
3y CAGR+8.5%
5y CAGREarnings
$29.493m
-163.6%
1y CAGR+52.2%
3y CAGR+47.1%
5y CAGREPS
$0.11
-167.5%
1y CAGR+48.2%
3y CAGR+44.9%
5y CAGRBook Value
$4.532b
$11.860b
Assets$7.327b
Liabilities$5.417b
DebtDebt to Assets
45.7%
38.9x
Debt to EBITDAFree Cash Flow
$1.246b
-7.4%
1y CAGR+18.9%
3y CAGR+15.6%
5y CAGRNo items found.
Press Releases
Statements and updates from the company